Eli Lilly & Co. delivered another blowout quarter, lifting its full-year forecast after earnings and revenue soared past Wall Street’s expectations — Read More
Tags :GLP-1 drugs
Eli Lilly & Co. delivered another blowout quarter, lifting its full-year forecast after earnings and revenue soared past Wall Street’s expectations — Read More